Cite

HARVARD Citation

    Pepin, A. et al. (n.d.). PO-1364 Bleeding Risk after Prostate SBRT in Men on Baseline Anticoagulant/Antiplatelet Therapy. Radiotherapy and oncology. pp. S1119-S1120. [Online]. 
  
Back to record